INDIANAPOLIS (Mirror Indy ... best known for introducing mass insulin production at Eli Lilly and Co. Woollen was 32 when he was chosen for the project. Because of his youth and relative inexperience, ...

INDIANAPOLIS (Mirror Indy ... best known for introducing mass insulin production at Eli Lilly and Co. Woollen was 32 when he was chosen for the project. Because of his youth and relative ...

Sales of Lilly’s top-selling product, the diabetes treatment Mounjaro, jumped 60% to $3.53 billion in the final quarter of ...

Analysts expect the Indianapolis, Indiana-based company to report quarterly earnings at $5.08 per share, up from $2.49 per ...

OliX Pharmaceuticals announced a global licensing agreement with Eli Lilly (LLY). This collaboration focuses on the development and ...

The drugmaker’s financial forecasts topped Wall Street’s expectations, reassuring investors after it overestimated demand for ...

Thanks to impressive sales growth across multiple therapeutic areas in 2024, Eli Lilly ... the sum the Indianapolis-based drugmaker generated during the same period in 2023. Lilly didn’t mince ...

With a market cap of $799.5 billion, Indianapolis, Indiana-based Eli Lilly and Company (LLY) is a leading global pharmaceutical firm renowned for its innovative contributions to healthcare.

Eli Lilly has named Winselow Tucker as President and General Manager for India. Tucker will oversee operations, including the Lilly India commercial organization and the Lilly Capability Centre India.

Eli Lilly’s profit doubled in the fourth quarter ... States as a treatment for some forms of sleep apnea. For 2025, the Indianapolis drugmaker expects adjusted earnings to range between $ ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast.